BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

778 related articles for article (PubMed ID: 28165675)

  • 1. Intratracheal Administration of Budesonide-Surfactant in Prevention of Bronchopulmonary Dysplasia in Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis.
    Venkataraman R; Kamaluddeen M; Hasan SU; Robertson HL; Lodha A
    Pediatr Pulmonol; 2017 Jul; 52(7):968-975. PubMed ID: 28165675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia.
    Yeh TF; Chen CM; Wu SY; Husan Z; Li TC; Hsieh WS; Tsai CH; Lin HC
    Am J Respir Crit Care Med; 2016 Jan; 193(1):86-95. PubMed ID: 26351971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Intratracheal Administration of Corticosteroid and Pulmonary Surfactant for Preventing Bronchopulmonary Dysplasia in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Meta-analysis.
    Zhong YY; Li JC; Liu YL; Zhao XB; Male M; Song DK; Bai Y
    Curr Med Sci; 2019 Jun; 39(3):493-499. PubMed ID: 31209823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical efficacy of pulmonary surfactant combined with budesonide for preventing bronchopulmonary dysplasia in very low birth weight infants].
    Pan J; Chen MW; Ni WQ; Fang T; Zhang H; Chen Y; Pan JH
    Zhongguo Dang Dai Er Ke Za Zhi; 2017 Feb; 19(2):137-141. PubMed ID: 28202108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surfactant instillation in spontaneously breathing preterm infants: a systematic review and meta-analysis.
    Rigo V; Lefebvre C; Broux I
    Eur J Pediatr; 2016 Dec; 175(12):1933-1942. PubMed ID: 27678511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and safety of early combined utilization of budesonide and surfactant by airway for bronchopulmonary dysplasia prevention in premature infants with RDS: A meta-analysis.
    Tang W; Chen S; Shi D; Ai T; Zhang L; Huang Y; Fan Y; Du Y
    Pediatr Pulmonol; 2022 Feb; 57(2):455-469. PubMed ID: 34783192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of different inhaled corticosteroids for bronchopulmonary dysplasia prevention in preterm infants: A systematic review and meta-analysis.
    Zhang M; Zhang W; Liao H
    Respir Med Res; 2024 Jun; 85():101096. PubMed ID: 38744231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratracheal Instillation of Budesonide-Surfactant for Prevention of Bronchopulmonary Dysplasia in Extremely Premature Infants.
    Dolma K; Zayek M; Gurung A; Eyal F
    Am J Perinatol; 2024 May; 41(S 01):e3065-e3073. PubMed ID: 37913780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Effects of Intratracheal Budesonide and Surfactant for the Prevention of Bronchopulmonary Dysplasia: A Narrative Review.
    Nobile S; Di Sipio Morgia C; Hall M
    Am J Perinatol; 2024 May; 41(S 01):e1858-e1865. PubMed ID: 37279790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of intratracheal administration of budesonide combined with pulmonary surfactant in preventing bronchopulmonary dysplasia: a prospective randomized controlled trial.
    Liu MM; Ji L; Dong MY; Zhu XF; Wang HJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jan; 24(1):78-84. PubMed ID: 35177180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratracheal administration of budesonide with surfactant in very low birth weight infants to prevent bronchopulmonary dysplasia.
    Heo M; Jeon GW
    Turk J Pediatr; 2020; 62(4):551-559. PubMed ID: 32779407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: study protocol for the international, multicenter, randomized PLUSS trial.
    Manley BJ; Kamlin COF; Donath S; Huang L; Birch P; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Wilson R; Davis PG; McKinlay CJD
    Trials; 2023 May; 24(1):320. PubMed ID: 37161488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Airway administration of corticosteroids for prevention of bronchopulmonary dysplasia in premature infants: a meta-analysis with trial sequential analysis.
    Zhang ZQ; Zhong Y; Huang XM; Du LZ
    BMC Pulm Med; 2017 Dec; 17(1):207. PubMed ID: 29246209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trial.
    Francis KL; McKinlay CJD; Kamlin COF; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Davis PG; Donath SM; Manley BJ
    Trials; 2023 Nov; 24(1):709. PubMed ID: 37932774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intra-tracheal surfactant/budesonide versus surfactant alone: Comparison of two consecutive cohorts of extremely preterm infants.
    Moschino L; Nardo D; Bonadies L; Stocchero M; Res G; Priante E; Salvadori S; Baraldi E
    Pediatr Pulmonol; 2021 Jul; 56(7):2114-2124. PubMed ID: 33942570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and outcome data of very low birth weight infants treated with less invasive surfactant administration in comparison to intubation and mechanical ventilation in the clinical setting of a cross-sectional observational multicenter study.
    Langhammer K; Roth B; Kribs A; Göpel W; Kuntz L; Miedaner F
    Eur J Pediatr; 2018 Aug; 177(8):1207-1217. PubMed ID: 29808237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review and Meta-analysis.
    Isayama T; Iwami H; McDonald S; Beyene J
    JAMA; 2016 Aug; 316(6):611-24. PubMed ID: 27532916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants.
    Rastogi A; Akintorin SM; Bez ML; Morales P; Pildes RS
    Pediatrics; 1996 Aug; 98(2 Pt 1):204-10. PubMed ID: 8692619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review shows that using surfactant a number of times or as a vehicle for budesonide may reduce the risk of bronchopulmonary dysplasia.
    Hascoët JM; Picaud JC; Ligi I; Blanc T; Daoud P; Zupan V; Moreau F; Guilhoto I; Rouabah M; Alexandre C; Saliba E; Storme L; Patkai J; Pomedio M; Hamon I
    Acta Paediatr; 2018 Jul; 107(7):1140-1144. PubMed ID: 29193276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.